How I manage patients with inherited haemophilia A and B and factor inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|4|501-510

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.4, 2018-02, pp. : 501-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Haemophilia pseudotumours in patients with inhibitors

By  

HAEMOPHILIA, Vol. 1351-8216, Iss. 5, 2015-09 ,pp. : 681-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemophilia pseudotumours in patients with inhibitors

By  

HAEMOPHILIA, Vol. 21, Iss. 5, 2015-09 ,pp. : 681-685

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

By  

HAEMOPHILIA, Vol. 21, Iss. 3, 2015-05 ,pp. : 374-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Results of a phase I/II open‐label, safety and efficacy trial of coagulation factor IX (recombinant), albumin fusion protein in haemophilia B patients

By  

HAEMOPHILIA, Vol. 21, Iss. 6, 2015-11 ,pp. : 784-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

How do I manage Rh typing in obstetric patients?

By  

TRANSFUSION, Vol. 55, Iss. 3, 2015-03 ,pp. : 470-474

John Wiley & Sons Inc

Access to resources Recommend Favorite